Addiction

Sober Safe Spot at Louisiana Culture Festival

NEW ORLEANS, LOUISIANA / ACCESS Newswire / January 17, 2025 / We are excited to announce the arrival of Sober…

11 months ago

Kipu Health Survey: Leaders Say Tech is Key to Fighting Addiction and Reducing Relapse

84% of behavioral health leaders believe technology can cut relapse rates amid ongoing staffing challenges MIAMI, Jan. 16, 2025 /PRNewswire/…

11 months ago

A Groundbreaking Forum at HIMSS25 Focused on Behavioral Health

LAS VEGAS, Jan. 15, 2025 /PRNewswire/ -- Informa Connect announces a landmark collaboration with Behavioral Health Tech to present the…

11 months ago

Optimi Health Reports First Patients Dosed in Landmark Natural Psilocybin Study in New Zealand

The Company's natural psilocybin extract powers a culturally transformative study to address methamphetamine addiction through indigenous frameworks.Vancouver, British Columbia--(Newsfile Corp.…

11 months ago

Achieve Life Sciences Appoints Dr. Kristen Slaoui and Nancy Phelan to its Board of Directors

New Directors Bring Extensive Leadership Experience in Corporate Strategy and CommercializationSEATTLE and VANCOUVER, British Columbia, Jan. 10, 2025 (GLOBE NEWSWIRE)…

12 months ago

Pacira Announces New Five-Year Objectives to Accelerate Transition into an Innovative Biopharmaceutical Organization

Company also reports preliminary unaudited 2024 revenue of $701.0 millionPARSIPPANY, N.J., Jan. 10, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc.…

12 months ago

Ensysce Biosciences Issues Annual Shareholder Letter

~ FDA Breakthrough Therapy designation received for PF614-MPAR ~~ PF614-MPAR second clinical trial initiated ~~ Lead clinical candidate identified for…

12 months ago

PhenQ Reviews: Legit Fat Burner Supplement or Scam Weight Loss Pills?

PhenQ is a natural weight management system that targets five major areas of metabolic health, providing a holistic solution for…

12 months ago

Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present January 12 at the Annual Neuroscience Innovation Forum

Magdalena aiming to submit Investigational New Drug (IND) application in early 2025 to the FDA for a next-generation psychoactive prescription…

12 months ago

Achieve Life Sciences Announces Critical Milestone Successfully Reached in ORCA-OL Cytisinicline Clinical Trial Required for NDA Submission

Over 300 Participants Have Completed Cumulative Six Months of Cytisinicline Treatment in the ORCA-OL Trial, Completing the Long-Term Exposure Requirement…

12 months ago